(Q34759063)

English

Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Alzheimer's disease

0 references

0 references

1 reference

ORCID Public Data File 2021

author name string

Keith A Wesnes

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

6 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Neurodegenerative Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

261-263

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Benefits of rivastigmine on attention in dementia associated with Parkinson disease

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

The cognitive drug research computerized assessment system for demented patients: A validation study

1 reference

https://api.crossref.org/works/10.1159%2F000113719

21 January 2018

Identifiers

10.1159/000113719

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34759063&oldid=1577849402"